DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Menu 返回 CMC-and-Quality

CMC, Quality, GMP

The Regulatory CMC (Chemistry, Manufacturing and Controls) and Product Quality Track provides a comprehensive overview of risk-based approaches throughout the product lifecycle.

The scope of the track spans scientific understanding gained through product and process development to lifecycle expectations for Global Regulatory CMC submissions, CGMP, and Quality Systems. Sessions address the increasing regulatory complexity in development and manufacturing for worldwide markets, global harmonisation, early patient access, pandemic medicines, new technologies, emerging regulations and the increasing scrutiny of manufacturing operations and data.

Who is This Track Designed For?

Professionals involved in CMC regulatory affairs and policy, manufacturing, quality assurance, quality control, drug development and/or manufacturing for small molecule drugs, biologics, vaccines and all modalities (ATMPs, oligonucleotides, etc).

Register Now

DIA Europe 2022 Brochure

The online program is now available. Explore the rich content we offer across 10 thought leadership tracks. 

View Searchable Programme

Topic Leaders

Diane Wilkinson

Diane Wilkinson, PhD, RPh

Senior Director, Global CMC Regulatory Affairs

Astrazeneca, United Kingdom

Matt Popkin

Matt Popkin, PhD

Director, CMC Strategy

GlaxoSmithKline, United Kingdom

DIA Europe 2022 Highlights

It will provide updates on key developments on the GCP Renovation (ICH E6, ICH E8), Clinical Trial Regulation, the Clinical Trial Information System, data submission, transparency, navigating ethical approval, study design in the digital age, innovative clinical trial designs (umbrella and platform trials, patient centricity), digital tools in development and other hot topics. It should be a must-attend for optimising development programmes and identifying cost savings through efficiency and innovation.


Explore All Tracks

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。